NIST will invest an initial $20 million in a new Quantum Manufacturing Engineering Center (QMEC) run by SRI International, the nonprofit R&D organization, under an agreement announced in Gaithersburg, Md. The center's mandate is narrow and specific: accelerate the manufacture of scalable, high-performance quantum components and systems for the U.S. quantum industry.

The choice of target reflects what NIST's own engagement with industry revealed. Through the Quantum Economic Development Consortium (QED-C), which NIST and SRI jointly established in 2019 in response to the National Quantum Initiative Act, the agency concluded that quantum manufacturing engineering — not quantum physics — is the critical gap in national efforts to build a robust commercial quantum sector. QED-C's membership now includes essentially all major U.S. commercial developers of quantum technologies plus a growing base of end users, giving NIST an unusually direct read on where lab-to-fab translation stalls.

"Quantum science promises to generate new knowledge and technologies that will supercharge scientific research and unlock enormous economic potential," said Deputy Secretary of Commerce Paul Dabbar. "The new Quantum Manufacturing Engineering Center will bring together top experts to ensure both continued U.S. leadership in quantum technologies and that we are the epicenter of manufacturing quantum systems at scale to drive advances in sensing, communications, encryption, computing, biomedicine and other critical areas."

Policy basis and timing

The agreement implements the Executive Order on Ushering in the Next Frontier of Quantum Innovation, dated June 22, 2026, and advances NIST's Strategy for American Technology Leadership in the 21st Century. The executive order calls for advancing "the commercial readiness of quantum sensing and quantum-sensor manufacturing" by "supporting research and development pathways that advance quantum-enabling technologies and eliminate manufacturing barriers" — language that maps closely onto the QMEC's stated mission.

"NIST is a world leader in quantum science and technology based on decades of fundamental research that helped launch the U.S. quantum industry," said Under Secretary of Commerce for Standards and Technology and NIST Director Arvind Raman. "This public-private partnership with SRI International will accelerate the development of America's quantum industrial base — the foundation upon which the quantum revolution is being built."

What the center will actually do

SRI brings a track record of transitioning emerging technologies into commercial use. NIST expects QMEC to deliver research and engineering results that remove specific manufacturing barriers and demonstrate market adoption — a phrasing that puts adoption, not publication, at the success criterion. The announcement does not yet specify target component classes, performance metrics, or a timeline, so the $20 million initial investment remains the only quantified commitment.

For measurement and test engineers, the implication is concrete. Quantum sensing, communications, and computing systems depend on components whose specifications — coherence times, noise floors, detection efficiencies — are set at the manufacturing stage. A center dedicated to manufacturing engineering signals that yield, reproducibility, and process control for such components are now treated as first-order national priorities rather than downstream concerns.

The agreement also fits a broader NIST plan to coordinate research for accelerating deployment of critical technologies in national priority areas — including AI, quantum information science and technology, and biotechnology — using adaptive, flexible public-private partnerships.

The open question for instrument makers and quantum-component suppliers is whether QMEC will define the qualification standards and test methodologies that manufacturing-scale quantum hardware currently lacks — and whether $20 million is enough capital to close a gap that spans sensing, communications, encryption, computing, and biomedicine.